Bioprinted tissues require integrated functional vasculature to survive and perform after transplantation because diffusion alone cannot sustain cells beyond a few hundred micrometers. Failure to establish perfusion leads to central necrosis, graft failure, and wasted resources. Researchers have pursued multiple complementary strategies to create vascular networks that can connect with the host circulation and sustain complex tissue constructs.
Scaffold-guided and sacrificial-channel approaches
One route is printing templates that form channels which can be lined with endothelial cells. Jennifer A. Lewis at Harvard University and the Wyss Institute has advanced sacrificial ink techniques that produce perfusable conduits within hydrogel matrices; removing the sacrificial material leaves open channels that support endothelialization and immediate perfusion. These engineered channels shorten the time to blood perfusion after implantation, reducing ischemic injury and improving early graft survival.
Cellular self-assembly and growth-factor guidance
An alternative relies on biological programing: co-printing endothelial cells with supporting perivascular cells and extracellular matrix cues encourages angiogenesis and vascular network self-assembly. Gordana Vunjak-Novakovic at Columbia University has demonstrated the importance of mechanical and biochemical signals in guiding vessel morphogenesis in vitro. Delivering gradients of pro-angiogenic factors such as vascular endothelial growth factor can accelerate capillary sprouting and promote connections with host microvasculature, though controlling vessel architecture remains challenging.
Microfluidics, pre-vascularization, and inosculation
Microfluidic bioreactors and pre-vascularization strategies aim to mature vessels before implantation so they can rapidly inosculate with host blood vessels. Anthony Atala at Wake Forest Institute for Regenerative Medicine has emphasized creating tissue units with preformed vascular beds to improve translational readiness. Integrating perfusable microchannels with living endothelial linings creates constructs that tolerate surgical implantation and immediate perfusion. Robert Langer at Massachusetts Institute of Technology and colleagues have explored biomaterials and controlled release systems to support long-term vascular stability.
These methods have distinct causes and consequences: channel printing and microfluidics provide immediate perfusion but may yield non-physiologic architecture, while self-assembly yields more natural capillary networks but risks delayed perfusion. Clinically, successful vascular integration promises to alleviate organ shortages, reduce reliance on donor tissue, and decrease animal testing, yet it raises regulatory, ethical, and access questions. Geographic concentration of expertise and manufacturing capacity in certain research centers may affect equitable access to these therapies. Ongoing multidisciplinary work across materials science, cell biology, and surgery is essential to move bioprinted, vascularized tissues from lab demonstrations to safe, effective transplantation.